Rani Therapeutics Holdings, Inc. (RANI) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.60
-1.26%
Mkt Cap $39.80M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $5.00M | $1.46M | -70.78% | -$0.03 | -$0.07 | -133.33% |
| Q4 2025 Nov 6, 2025 | $5.00M | — | — | -$0.09 | -$0.12 | -33.33% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.19 | -$0.18 | +5.26% |
| Q2 2025 May 13, 2025 | — | $172.00K | — | -$0.22 | -$0.22 | +0.00% |
| Q1 2025 Mar 31, 2025 | — | $1.03M | — | -$0.24 | -$0.27 | -12.50% |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.22 | -$0.24 | -9.09% |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.29 | -$0.26 | +10.34% |
| Q2 2024 May 6, 2024 | — | — | — | -$0.23 | -$0.29 | -26.09% |
| Q1 2024 Mar 20, 2024 | — | $2.75M | — | -$0.31 | -$0.27 | +12.90% |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.47 | -$0.36 | +23.40% |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.40 | -$0.37 | +7.50% |
| Q2 2023 May 10, 2023 | — | — | — | -$0.47 | -$0.33 | +29.79% |
| Q1 2023 Mar 22, 2023 | $108.33K | — | — | -$0.26 | -$0.35 | -34.62% |
| Q4 2022 Nov 10, 2022 | $110.00K | — | — | -$0.33 | -$0.33 | +0.00% |
| Q3 2022 Aug 10, 2022 | $130.00K | — | — | -$0.28 | -$0.31 | -10.71% |
| Q2 2022 May 11, 2022 | $325.00K | — | — | -$1.00 | -$0.29 | +71.00% |
| Q1 2022 Mar 29, 2022 | $162.50K | -$2.72M | -1772.00% | -$1.28 | -$0.27 | +78.91% |
| Q4 2021 Nov 15, 2021 | $490.00K | — | — | -$0.21 | -$0.16 | +23.81% |
| Q3 2021 Sep 13, 2021 | — | $1.96M | — | -$0.18 | -$0.12 | +33.33% |
| Q3 2021 Aug 2, 2021 | — | $756.00K | — | — | -$0.30 | — |
| Q4 2020 Dec 31, 2020 | — | $210.00K | — | — | -$0.89 | — |
| Q3 2020 Sep 30, 2020 | — | $108.00K | — | — | -$0.15 | — |
| Q2 2020 Jun 30, 2020 | — | $60.00K | — | — | -$0.14 | — |
| Q1 2020 Mar 31, 2020 | — | $83.00K | — | — | -$0.29 | — |